Gennemsnitlige IOP- reduktioner var non- inferior, selv om de var numerisk lavere, end dem, der blev opnået ved samtidig behandling med travoprost 40 mikrogram/ ml doseret en gang daglig om aftenen og timolol 5 mg/ ml doseret en gang daglig om morgenen.
Mean IOP reductions were non-inferior, although numerically lower, to those achieved by concomitant therapy with travoprost 40 micrograms/ ml dosed once-daily in the evening and timolol 5 mg/ ml dosed once-daily in the morning.